Proteonomix (PROT) Stock Price, News & Analysis

Company Overview

Proteonomix, Inc. is a life sciences company specializing in advanced sample preparation solutions for proteomics and mass spectrometry applications. The company develops and markets paramagnetic bead–based technologies designed to streamline workflows in biological research, drug discovery and clinical diagnostics. By focusing on robust, reproducible methods for protein and peptide enrichment, Proteonomix aims to accelerate insights in areas such as biomarker discovery, post-translational modification analysis and therapeutic development.

The company’s product portfolio includes proprietary magnetic bead chemistries and preformatted kits that address common proteomic challenges, including phosphopeptide enrichment, histone purification and immunoaffinity capture of low-abundance targets. These offerings are complemented by custom reagent development services, technical support and protocol optimization to help researchers tailor workflows to specific sample types and analytical platforms. Proteonomix also collaborates with instrument manufacturers and academic laboratories to validate new applications and ensure compatibility across a range of mass spectrometry systems.

Proteonomix serves a global customer base encompassing academic institutions, biopharmaceutical companies, contract research organizations and government laboratories. Through a network of distribution partners in North America, Europe and Asia-Pacific, the company provides timely access to its products and localized technical assistance. Ongoing investment in research and development supports expansion into emerging markets such as single-cell proteomics and spatially resolved protein analysis, reflecting Proteonomix’s commitment to meeting evolving needs in life science research.

Founded in the early 2010s and headquartered in the United States, Proteonomix is led by a management team of industry veterans with extensive experience in proteomics, biotechnology and analytical chemistry. The company’s leadership combines scientific expertise and entrepreneurial acumen to guide strategic growth, drive product innovation and expand global market reach. Through its suite of sample preparation solutions, Proteonomix continues to support the proteomics community in achieving higher throughput, greater sensitivity and improved reproducibility in protein analysis workflows.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 43,100 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

PROT Stock Analysis - Frequently Asked Questions

How do I buy shares of Proteonomix?

Shares of PROT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:PROT
• CIK: 1000897
• Web: stromacel.com
• Phone: (973) 949-4195
• Fax: N/A
• Employees: 5
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A